Author Archives: Darren Marchal

Here’s What’s Driving Your Investment Returns

Although your investment results may seem random, they aren’t. In reality, your portfolio’s performance is directly influenced by a number of decisions you’ve consciously or unconsciously made. Let’s examine the factors driving your returns. Your Asset Mix Back in the 1990s, Gary Brinson’s landmark study highlighted the acute impact of a portfolio’s returns by how…

Michigan Consumer Sentiment: May Preliminary Unchanged

The University of Michigan Preliminary Consumer Sentiment for May came in at 98.8, unchanged from the April Final reading. Investing.com had forecast 98.5. Surveys of Consumers chief economist, Richard Curtin, makes the following comments: Consumer sentiment remained unchanged in early May from the April survey. The Expectations Index gained 1.1 points and the Current Conditions Index fell…

3 Best Technology Mutual Funds For Impressive Returns

Risk lovers seeking healthy returns over a fairly long investment horizon may opt for technology mutual funds. It is believed that the technology sector is poised for a brighter earnings performance than the other sectors due to greater demand for technology and innovation. Improving industry fundamentals and emerging technologies such as wearables, VR headsets, drones,…

Weekend Reading: The Art Of War

“Strategy without tactics is the slowest route to victory. Tactics without strategy is the noise before defeat.” – Sun Tzu: The Art Of War The biggest mistake investors make over the long-term is investing without a strategy. The point that Sun Tzu was making, as it relates to investing, is that having a strategy, such as buying…

Bull Of The Day: Exelixis

Exelixis (EXEL – Free Report) is a $6 billion biotechnology company focused on cancer R&D and the producer of cabozantinib (sold under the brand names Cabometyx and Cometriq), a treatment approved by the FDA for several indications: medullary thyroid cancer, a second line treatment for renal cell carcinoma (RCC), and clinical activity in several other types of metastatic…